Publicaciones en colaboración con investigadores/as de Swiss Federal Institute of Technology in Zurich (11)

2014

  1. Diagnostic and therapeutic uses of nanomaterials in the brain

    Current Medicinal Chemistry, Vol. 21, Núm. 36, pp. 4100-4131

2013

  1. Efficacy of edelfosine lipid nanoparticles in breast cancer cells

    International Journal of Pharmaceutics, Vol. 454, Núm. 2, pp. 720-726

2004

  1. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres

    Journal of Controlled Release, Vol. 96, Núm. 3, pp. 437-448

  2. New therapeutic approaches for the treatment of Brucella infections: Gentamicin entrapment into drug delivery systems

    Current Medicinal Chemistry: Anti-Infective Agents, Vol. 3, Núm. 1, pp. 43-56

2003

  1. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters

    Journal of Microencapsulation, Vol. 20, Núm. 5, pp. 553-567

2000

  1. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres

    Journal of Controlled Release, Vol. 67, Núm. 1, pp. 19-28

1999

  1. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres

    International Journal of Pharmaceutics, Vol. 184, Núm. 2, pp. 243-250

  2. Two methods to encapsulate a somatostatin analogue into PLGA microspheres

    Proceedings of the Controlled Release Society

1998

  1. Co-encapsulation of additives improved entrapment and release of a somatostatin analog in PLGA micropsheres

    Proceedings of the Controlled Release Society

  2. Nouvelles approches pour l'encapsulation de peptides au sein de microspheres de PLG

    Annales Pharmaceutiques Francaises, Vol. 56, Núm. 6, pp. 256-263

1997

  1. In vitro and in vivo release kinetics of a somatostatin analogue from PLGA microspheres

    Proceedings of the Controlled Release Society